{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:04:17Z","timestamp":1791173057824,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1451,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.jacc.2009.05.051","type":"journal-article","created":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T12:42:07Z","timestamp":1253104927000},"page":"1165-1172","source":"Crossref","is-referenced-by-count":142,"title":["Normal Plasma Levels of Cardiac Troponin I Measured by the High-Sensitivity Cardiac Troponin I Access Prototype Assay and the Impact on the Diagnosis of Myocardial Ischemia"],"prefix":"10.1016","volume":"54","author":[{"given":"Per","family":"Venge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertil","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2009.05.051_bib1","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jacc.2007.09.011","article-title":"Universal definition of myocardial infarction","volume":"50","author":"Thygesen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.05.051_bib2","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1056\/NEJMoa0707064","article-title":"Use of multiple biomarkers to improve the prediction of death from cardiovascular causes","volume":"358","author":"Zethelius","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.05.051_bib3","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1161\/CIRCULATIONAHA.105.570762","article-title":"Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study","volume":"113","author":"Zethelius","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.05.051_bib4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1373\/clinchem.2006.084715","article-title":"National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes","volume":"53","author":"Apple","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2009.05.051_bib5","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1373\/clinchem.2007.095679","article-title":"National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal pro\u2013B-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure","volume":"53","author":"Wu","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2009.05.051_bib6","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1373\/49.6.880","article-title":"Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits","volume":"49","author":"Venge","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2009.05.051_bib7","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1161\/CIRCULATIONAHA.107.708529","article-title":"Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality","volume":"116","author":"Eggers","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.05.051_bib8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1373\/clinchem.2006.076885","article-title":"Long-term health outcomes associated with detectable troponin I concentrations","volume":"53","author":"Kavsak","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2009.05.051_bib9","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1373\/clinchem.2005.064857","article-title":"The antibody configurations of cardiac troponin I assays may determine their clinical performance","volume":"52","author":"James","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2009.05.051_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0002-9343(03)00348-6","article-title":"Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO IV trial","volume":"115","author":"James","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2009.05.051_bib11","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.CIR.0000046487.06811.5E","article-title":"Long-term results after the glycoprotein IIb\/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV\u2013Acute Coronary Syndrome) trial","volume":"107","author":"Ottervanger","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2009.05.051_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.clinbiochem.2003.11.002","article-title":"Biochemical indicators of cardiac and renal function in a healthy elderly population","volume":"37","author":"Johnston","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jacc.2009.05.051_bib13","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1373\/clinchem.2005.064857","article-title":"The antibody configurations of cardiac troponin I assays may determine their clinical performance","volume":"52","author":"James","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2009.05.051_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(00)02427-2","article-title":"Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial","volume":"356","author":"Wallentin","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2009.05.051_bib15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(99)07350-X","article-title":"Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2009.05.051_bib16","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(00)05060-1","article-title":"Effect of glycoprotein IIb\/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial","volume":"357","author":"Simoons","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2009.05.051_bib17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1373\/clinchem.2008.116020","article-title":"Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury","volume":"55","author":"Kavsak","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2009.05.051_bib18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/000456328702400115","article-title":"Estimation of imprecision in immunoassay quality assessment programmes","volume":"24","author":"Sadler","year":"1987","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jacc.2009.05.051_bib19","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1093\/clinchem\/47.12.2137","article-title":"Effect of outliers and nonhealthy individuals on reference interval estimation","volume":"47","author":"Horn","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2009.05.051_bib20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0002-9149(94)90739-0","article-title":"Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA trial)","volume":"74","author":"Diver","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.05.051_bib21","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0735-1097(01)01501-7","article-title":"Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy","volume":"38","author":"Lindahl","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.05.051_bib22","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s001340100970","article-title":"Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression?","volume":"27","author":"Wu","year":"2001","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jacc.2009.05.051_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2006.02.056","article-title":"Biomarkers in acute cardiac disease: the present and the future","volume":"48","author":"Jaffe","year":"2006","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709021974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709021974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T06:58:02Z","timestamp":1590130682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109709021974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":23,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0735109709021974"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2009.05.051","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}